Arietis Pharma Is A Boston Based Biotechnology Company Focused On The Discovery And Development Of Novel Antimicrobial Agents Our Drug Discovery Pipeline Focuses On Sterilizing Antibiotics That Target Staphylococcus Aureusa Leading Cause Of Nosocomial And Community Acquired Infectionsand Helicobacter Pyloria Cause Of Gastric Ulcers And Cancer Pathogenic Bacteria Continually Develop And Spread Resistancecausing The Efficacy Of Antibiotics To Diminish With Time Antibiotics Are Indispensable For Basic Healthcare And Enable Much Of Modern Medicinewithout Themroutine Surgeries And Superficial Infections Could Become Life Threatening Founded In 2006Arietis Bridges An Important Gap In Antimicrobial Drug Discovery And Development Arietis Has Forged Productive Alliances And Partnerships Within The Biotechnology Community As We Advance Our Capacity To Develop Effective Antibacterialsarietis Is Committed To Building Value For Its Partnersshareholdersand Society As A Whole By Providing Innovative Solutions For The Problems Of Antibiotic Tolerance And Resistant Infections
